000 01142 a2200277 4500
005 20250516165113.0
264 0 _c20140107
008 201401s 0 0 eng d
022 _a1558-3597
024 7 _a10.1016/j.jacc.2013.05.087
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGenest, Jacques
245 0 0 _aHigh-density lipoprotein and residual cardiovascular risk: De minimis non curat medicus or the COURAGE to be SMART?
_h[electronic resource]
260 _bJournal of the American College of Cardiology
_cNov 2013
300 _a1842-4 p.
_bdigital
500 _aPublication Type: Editorial; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAnticholesteremic Agents
_xadministration & dosage
650 0 4 _aCholesterol, HDL
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMyocardial Ischemia
_xblood
773 0 _tJournal of the American College of Cardiology
_gvol. 62
_gno. 20
_gp. 1842-4
856 4 0 _uhttps://doi.org/10.1016/j.jacc.2013.05.087
_zAvailable from publisher's website
999 _c23030924
_d23030924